Company intelligence / Profile preview

Pharmatest Services

Ownership: Private
Development stage: Other

Overview

Pharmatest offers clinically predictive preclinical research services to establish proof-of-efficacy for oncology and skeletal disease drug candidates. Their advanced cell culture assays and animal models are designed to closely mimic human disease conditions. They have served over 100 pharmaceutical, biotechnology, and nutraceutical companies worldwide. No proprietary clinical results as they do not develop drugs themselves.

Therapeutic areas: OncologyEndocrinologyRheumatology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Pharmatest Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmatest Services.

Explore the full profile